Rytary Interactions
There are 520 drugs known to interact with Rytary (carbidopa/levodopa), along with 13 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 50 are major, 459 are moderate, and 11 are minor.
- View all 520 medications that may interact with Rytary
- View Rytary alcohol/food interactions (1)
- View Rytary disease interactions (13)
Most frequently checked interactions
View interaction reports for Rytary (carbidopa / levodopa) and the medicines listed below.
- amantadine
- amlodipine
- aspirin
- atorvastatin
- Azilect (rasagiline)
- clonazepam
- CoQ10 (ubiquinone)
- duloxetine
- Eliquis (apixaban)
- entacapone
- gabapentin
- levothyroxine
- lisinopril
- losartan
- melatonin
- midodrine
- MiraLAX (polyethylene glycol 3350)
- omeprazole
- pantoprazole
- pramipexole
- rasagiline
- ropinirole
- rosuvastatin
- sertraline
- tamsulosin
- trazodone
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Rytary alcohol/food interactions
There is 1 alcohol/food interaction with Rytary (carbidopa / levodopa).
Rytary disease interactions
There are 13 disease interactions with Rytary (carbidopa / levodopa) which include:
- glaucoma
- cardiac disease
- neuroleptic malignant syndrome
- psychoses/depression
- glaucoma
- liver/renal
- melanoma
- reactive airway disease
- depression
- sleep disorders
- hypotension
- psychosis
- GI bleeding
Report options
QR code containing a link to this page
More about Rytary (carbidopa / levodopa)
- Rytary consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (30)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
